AXIM (AXIM Biotechnologies) Forward PE Ratio: 0.00 (As of Jul. 01, 2026)


What is AXIM Biotechnologies Forward PE Ratio?

AXIM Biotechnologies AXIM -6.67% Forward PE Ratio is 0.00 as of Jul. 01, 2026. The stock has 7 warning signs investors should review. Among 355 Biotechnology companies, AXIM Biotechnologies ranks worse than 281689.86% on this metric.

AXIM Biotechnologies's Forward PE Ratio for today is 0.00.

AXIM Biotechnologies's PE Ratio without NRI for today is 0.00.

AXIM Biotechnologies's PE Ratio (TTM) for today is 9999.00.

AXIM Biotechnologies  (OTCPK:AXIM) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

AXIM Biotechnologies Forward PE Ratio Related Terms

AXIM Biotechnologies Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies Forward PE Ratio Chart

AXIM Biotechnologies Annual Data
Trend
Forward PE Ratio

AXIM Biotechnologies Quarterly Data
Forward PE Ratio

AXIM vs ZVSA, HEPA, ISCO: Forward PE Ratio Comparison

For the Biotechnology subindustry, AXIM Biotechnologies's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AXIM Biotechnologies Forward PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AXIM Biotechnologies's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where AXIM Biotechnologies's Forward PE Ratio falls into.


AXIM Biotechnologies Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
AXIM Biotechnologies (AXIM) has a Forward PE Ratio of 0.00 as of Jul. 01, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on AXIM Biotechnologies and its competitors. According to the industry distribution chart, AXIM Biotechnologies ranks #999999 out of 355 companies in the Biotechnology industry.
Is AXIM Biotechnologies' Forward PE Ratio too high?
AXIM Biotechnologies' current Forward PE Ratio is 0.00. Based on the distribution chart, AXIM Biotechnologies ranks #999999 out of 355 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does AXIM Biotechnologies' Forward PE Ratio compare to ZVSA and HEPA?
According to the Biotechnology industry distribution chart, AXIM Biotechnologies ranks #999999 out of 355 companies for Forward PE Ratio. This places AXIM Biotechnologies in the lower half of its industry. The industry median Forward PE Ratio is 22.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Biotechnology company?
The median Forward PE Ratio among Biotechnology companies is 22.35, based on 355 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on AXIM Biotechnologies and its competitors. For the Biotechnology industry, the median Forward PE Ratio is 22.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AXIM Biotechnologies's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current Forward PE Ratio of 0.00. The current Forward PE Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Forward PE Ratio is 0.00 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.